Antifungal susceptibility profile of clinical Alternaria spp. identified by molecular methods

Ana Alastruey-Izquierdo1, Isabel Cuesta, Luis Ros

  • 1Servicio de Micología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda (Madrid), Spain. anaalastruey@isciii.es

Abstract

Insights

This study analyzed antifungal susceptibility in clinical Alternaria isolates. Results showed similar antifungal activity against Alternaria alternata and Alternaria infectoria, with echinocandins being an exception.

Area of Science:

  • Medical Mycology
  • Antimicrobial Resistance
  • Clinical Microbiology

Background:

  • Alternaria species are increasingly recognized as opportunistic fungal pathogens.
  • Clinical manifestations of Alternaria infections range from superficial to invasive diseases.
  • Understanding antifungal susceptibility patterns is crucial for effective treatment strategies.

Purpose of the Study:

  • To determine the antifungal susceptibility profiles of clinical isolates of Alternaria species.
  • To compare the activity of various antifungals against different Alternaria species.

Main Methods:

  • Thirty-five clinical Alternaria isolates were identified using internal transcribed spacer (ITS) region sequencing.
  • Antifungal susceptibility testing was performed according to European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines.

Main Results:

  • No significant differences in antifungal activity were observed between Alternaria alternata and Alternaria infectoria isolates for most tested agents.
  • Echinocandins demonstrated differential activity between the two species, warranting further investigation.

Conclusions:

  • Clinical isolates of Alternaria alternata and Alternaria infectoria exhibit similar susceptibility patterns to common antifungals.
  • Echinocandins may represent a distinct therapeutic option or challenge for specific Alternaria species infections.